Filing search / Aerovate Therapeutics, Inc. / "Tenure"

8-K

EX-99.1

AVTE Aerovate Therapeutics, Inc.

11 Jul 23

Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors

5:03pm

worked at Bayer AG where, over the course of his 22-year tenure, he served in roles of increasing responsibility, including Global Head, Neurology

8-K

EX-3.2

AVTE Aerovate Therapeutics, Inc.

2 Jul 21

Amendments to Articles of Incorporation or Bylaws

4:33pm

. Qualification. No officer need be a stockholder or a director. Any person may occupy more than one office of the Corporation at any time. SECTION 4. Tenure

S-1/A

EX-3.4

AVTE Aerovate Therapeutics, Inc.

17 Jun 21

IPO registration (amended)

4:35pm

. Qualification. No officer need be a stockholder or a director. Any person may occupy more than one office of the Corporation at any time. SECTION 4. Tenure

S-1

EX-3.3

AVTE Aerovate Therapeutics, Inc.

9 Jun 21

IPO registration

5:21pm

of the Board Section 2.7. Tenure and Resignation Section 2.8. Removal Section 2.9. Meetings Section 2.10. Notice of Meeting Section 2.11. Agenda … . Enumeration Section 3.2. Election Section 3.3. Qualification Section 3.4. Tenure Section 3.5. Removal Section 3.6. Resignation Section 3.7. Vacancies

DRS

EX-3.3

35jkmo

6 May 21

Draft registration statement

12:00am